Healthcare provider profile · identity verified

Netrali Patel, MD

Family Practice · THE VILLAGES, FL · NPI 1255596052

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	758	246
Rosuvastatin Calcium	Rosuvastatin Calcium	665	218
Levothyroxine Sodium	Levothyroxine Sodium	506	146
Amlodipine Besylate	Amlodipine Besylate	489	156
Losartan Potassium	Losartan Potassium	464	149
Lisinopril	Lisinopril	339	111
Omeprazole	Omeprazole	268	88
Metoprolol Succinate	Metoprolol Succinate	267	91
Gabapentin	Gabapentin	247	89
Pantoprazole Sodium	Pantoprazole Sodium	241	95
Metformin Hcl	Metformin Hcl	215	73
Pravastatin Sodium	Pravastatin Sodium	183	63
Ezetimibe	Ezetimibe	166	54
Simvastatin	Simvastatin	158	55
Tamsulosin Hcl	Tamsulosin Hcl	158	53
Trazodone Hcl	Trazodone Hcl	143	52
Eliquis	Apixaban	126	37
Meloxicam	Meloxicam	123	69
Metformin Hcl Er	Metformin Hcl	120	42
Famotidine	Famotidine	118	50
Hydrochlorothiazide	Hydrochlorothiazide	114	36
Duloxetine Hcl	Duloxetine Hcl	112	39
Montelukast Sodium	Montelukast Sodium	100	33
Escitalopram Oxalate	Escitalopram Oxalate	97	32
Metoprolol Tartrate	Metoprolol Tartrate	95	30
Atenolol	Atenolol	91	23
Allopurinol	Allopurinol	88	27
Clopidogrel	Clopidogrel Bisulfate	86	25
Fluticasone Propionate	Fluticasone Propionate	86	43
Sertraline Hcl	Sertraline Hcl	84	28
Fluoxetine Hcl	Fluoxetine Hcl	81	31
Potassium Chloride	Potassium Chloride	79	25
Alendronate Sodium	Alendronate Sodium	78	28
Valsartan	Valsartan	68	23
Carvedilol	Carvedilol	66	21
Furosemide	Furosemide	65	22
Albuterol Sulfate Hfa	Albuterol Sulfate	63	38
Doxazosin Mesylate	Doxazosin Mesylate	58	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	19
Citalopram Hbr	Citalopram Hydrobromide	54	15
Ozempic	Semaglutide	52	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	43	36
Bupropion Xl	Bupropion Hcl	41	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	16
Vitamin D2	Ergocalciferol (Vitamin D2)	41	31
Memantine Hcl	Memantine Hcl	40	13
Methylprednisolone	Methylprednisolone	39	38
Sildenafil Citrate	Sildenafil Citrate	39	18
Azithromycin	Azithromycin	37	34
Celecoxib	Celecoxib	37	13
Donepezil Hcl	Donepezil Hcl	37	15
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Lovastatin	Lovastatin	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	34	13
Glipizide	Glipizide	33	11
Spironolactone	Spironolactone	33	12
Tizanidine Hcl	Tizanidine Hcl	32	22
Prednisone	Prednisone	31	30
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Ramipril	Ramipril	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Mirtazapine	Mirtazapine	30	16
Ropinirole Hcl	Ropinirole Hcl	30	11
Prolia	Denosumab	29	21
Synthroid	Levothyroxine Sodium	29	13
Xarelto	Rivaroxaban	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Finasteride	Finasteride	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	26
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	12
Lansoprazole	Lansoprazole	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Glimepiride	Glimepiride	25	12
Myrbetriq	Mirabegron	25	suppressed
Amoxicillin	Amoxicillin	24	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Acyclovir	Acyclovir	22	11
Folic Acid	Folic Acid	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	14
Acarbose	Acarbose	21	suppressed
Primidone	Primidone	21	suppressed
Belsomra	Suvorexant	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Alprazolam	Alprazolam	18	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	18
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	11
Meclizine Hcl	Meclizine Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	15
Valacyclovir	Valacyclovir Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Ciclopirox	Ciclopirox	15	12
Estradiol	Estradiol	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Enalapril Maleate	Enalapril Maleate	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	11
Dilt-Xr	Diltiazem Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Nateglinide	Nateglinide	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error